Previous Page  14 / 28 Next Page
Information
Show Menu
Previous Page 14 / 28 Next Page
Page Background

SPD 2016

14-17 JULY 2016 •

MINNEAPOLIS,

MINNESOTA, USA

PracticeUpdate

Dermatology

Advisory

Board member Dr Sarah

Chamlin shares her top

sessions and take-aways

from the American

Society for Pediatric

Dermatology 2016 annual

meeting.

Dr Sarah Chamlin’s top 5

poster pearls fromSPD 2016

Sarah Chamlin MD, is Associate Professor of Pediatrics and Dermatology at

Northwestern University Feinberg School of Medicine, Attending Physician

at Children’s Memorial Hospital specialising in paediatric dermatology, and

Advisory Board member of

PracticeUpdate Dermatology

.

Paediatric

dermatology

literature year

in review

By Sarah Chamlin MD

K

evin Boyd MD from the University

of Alabama in Birmingham reviewed

articles published over the past year

relevant to paediatric dermatologists (Boyd

K. The Year in Review: Pediatrics. Paper pre-

sented at: 42nd Annual Society for Pediatric

Dermatology Meeting; July 14–17, 2016;

Minneapolis, MN).

Consensus communication on early peanut

introduction and the prevention of peanut

allergy in high-risk infants. Fleischer DM,

Sicherer S, Greenhawt M, et al.

Pediatrics

2015;136:600-604.

Early introduction of peanut to infants at

high risk for peanut allergy (ie, those with

a history of egg allergy or severe eczema) is

recommended to reduce this risk. The study

reported an 11% to 25% absolute reduction

in risk of developing peanut allergy in high-

risk infants. While dermatologists should

be aware of the LEAP trial (

N Engl J Med

1.

Tofacitinib is a promising future therapy for severe adolescent alopecia

areata.

In total, 13 patients with a median age of 15 years were treated with

tofacitinib, with 68% experiencing clinically significant growth. Adverse events

were mild and included headaches, upper respiratory infections, and mild

transaminitis.

2.

The common misperception that food plays a role in childhood atopic

dermatitis

persists for most parents (82%). In addition, most parents of

children with AD (58%) are unaware that infection can be a complicating

factor. These data were reported as part of a survey performed at a state fair

of 392 parents. Most parents get information about AD from their primary

care provider and the Internet.

3.

Allergic contact dermatitis is increasingly common in children.

Reports of adverse reactions, most commonly nickel-related dermatitis, to

common household toys or electronics such as iPads, laptops, and video game

controllers are on the rise. Consider these exposures when evaluating and

treating children with contact dermatitis.

4.

Evidence supports certain behavioural techniques to alleviate pre-

procedural anxiety and procedural pain perception for children

undergoing in-office procedures. The ideal timeframe to review the details

of the procedure with the child is 5 to 7 days beforehand. Counselling within

this timeframe may lessen anxiety. Children prepared for a painful procedure

by being told they would have “medium” pain experienced significantly less

pain than those not prepared.

5.

Clinical findings in AD patients vary among ethnicities

, and these

differing presentations can guide management. Hyperpigmentation, neck

lichenification, and lichen spinulosus are more common in black patients.

Follicular prominence is more common on the extensor surfaces of Asian

children and least common in non-Hispanic white children. Facial erythema

is more common in Asian and non-Hispanic white children. Infraorbital

fold involvement is less common in Asian children. Orbital darkening was

seen across all ethnicities, and white dermatographism was only observed in

white children. Of note, some of these findings that vary by races are listed

as Hanifin and Rajka minor criteria for AD.

PRACTICEUPDATE RHEUMATOLOGY & DERMATOLOGY

42ND ANNUAL MEETING OF THE SOCIETY FOR PEDIATRIC DERMATOLOGY

14